Latest filing published 06 Sept 2023 for 180 Life Sciences Corp.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Pamela G. Marrone span 2 companies, the busiest being Marrone Bio Innovations Inc and FORUM MARKETS Inc. Between 5 February 2016 and 4 September 2023, the trades on record add up to 21 filings.
On the open market, the record shows 2 purchases worth €11k and 8 sales worth €171k. On balance, insiders were net sellers of €160k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 6 share grants and 5 option exercises. In 2023 alone, the filings show 1 purchase and no sales.
On 6 September 2023 came the latest disclosure, a share grant in FORUM MARKETS Inc. The clock since the last published purchase (19 May 2023) now reads 1,248 days. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations